The accuracy of the cancer antigen (CA)–125 test in predicting ovarian cancer varies by ethnicity, primarily due to factors like age and comorbidities rather than ethnicity itself. General ...
Women with ovarian cancer exceeded the study goal of 150 minutes of brisk walking per week. Those in the exercise group also scored significantly better than controls on measures of fatigue. No ...
For the first time after years of frustrating failures, a rigorous study has found that a blood test for ovarian cancer can save lives, scientists running the largest-ever such trial reported on ...
Should I ask my doctor for a CA 125 blood test to screen for ovarian cancer? The cancer antigen 125 (CA 125) blood test isn't recommended for women with an average risk of ovarian cancer. While women ...
Current treatment guidelines recommend using cancer antigen-125 (CA-125) as a diagnostic marker for ovarian cancer recurrence, but a recent study suggests CA-125 has poor concordance with progressive ...
Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is an effective treatment for women with advanced ovarian cancer. Many women treated with NACT do not undergo IDS, and ...
(HealthDay News) – For women with ovarian cancer, metformin use is associated with significantly improved survival, according to a study published online Dec. 3 in Cancer. To examine the association ...
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American Indian ...
Many investigators have attempted to codify what degree of CA-125 elevation can predict progression of ovarian cancer with acceptable specificity and sensitivity. Although this serologic approach to ...
Verywell Health on MSN
The 3 types of ovarian cancer and how they are different
Epithelial ovarian carcinoma is the most common type of ovarian cancer. Germ cell tumors often affect teenagers and young ...
Neoadjuvant chemotherapy is the preferred treatment option for women with advanced ovarian and related cancers if it is unlikely that primary cytoreductive surgery (PCS) can reduce disease to less ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results